Gilead Sciences (GILD) '4997 Data 'Impressive & Underappreciated', KOL Suggests - Jefferies; PT to $95
Tweet Send to a Friend
Jefferies analyst Brian Abrahams reiterated a Buy rating and bumped his price target on Gilead Sciences (NASDAQ: GILD) to $95.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
